Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

New England Journal of Medicine(2023)10.1056/nejmoa2304146Source: DataRank Database

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection is a research paper published in New England Journal of Medicine (2023). On theSindex it has a DataRank of 5.1. It has been cited 468 times, with 100 citing works in its 1-hop citation network.

N/A

5.1DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access468 citations · 100 citing works in its network

Download PDF

Cite:

Linked data & code

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02344290

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 152.42)OA: greenTopics (31)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 18%Citation Network 82%

Base Score Contribution

0.923

From this paper's citation signal

Citation Network Contribution

4.2

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

HIV and Cardiovascular Disease — An Ounce of Prevention
New England Journal of Medicine202314 citations9 referencesContributes 0.301
CROI 2023: Metabolic and Other Complications of HIV Infection.
PubMed20237 citations8 referencesContributes 0.260
The Win Ratio Should Be Complemented by Other Win Statistics to Provide a Comprehensive Picture of Relative and Absolute Treatment Effects: The Case Study of the REPRIEVE Trial
Clinical Infectious Diseases20254 citations7 referencesContributes 0.230
Novel anti-obesity drugs for people with HIV
The Lancet HIV20245 citations11 referencesContributes 0.163
Low Prevalence of Coronary Artery Disease Among Ugandans With and Without HIV: Local Anomaly or Regional Reality?
Annals of Internal Medicine20254 citations10 referencesContributes 0.161

Authors (26)

Kathleen V. Fitch ORCID,Markella V. Zanni ORCID,Carl J. Fichtenbaum ORCID,Triin Umbleja ORCID,Judith A. Aberg ORCID

Live enrichment

PubMed:37486775 OpenAlex:https://openalex.org/W4385172574

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI068636

National Institute of Allergy and Infectious Diseases

Grant: UM1 AI106701

National Heart, Lung, and Blood Institute

Grant: U01HL123336

National Heart, Lung, and Blood Institute

Grant: U01HL123339

NIAID NIH HHS

Grant: UM1 AI069501

NIAID NIH HHS

Grant: UM1 AI069456

NIAID NIH HHS

Grant: UM1 AI069432

BLRD VA

Grant: I01 BX000207

NIAID NIH HHS

Grant: K24 AI157882

NIAID NIH HHS

Grant: UM1 AI069463

NIAID NIH HHS

Grant: U01 AI069424

NIAID NIH HHS

Grant: P30 AI050410

NIAID NIH HHS

Grant: UM1 AI069494

NIAID NIH HHS

Grant: UM1 AI069423

NHLBI NIH HHS

Grant: UG3 HL164285

NIDDK NIH HHS

Grant: P30 DK040561

NIAID NIH HHS

Grant: UM1 AI069470

NIAID NIH HHS

Grant: UM1 AI068634

NIAID NIH HHS

Grant: UM1 AI069496

NCATS NIH HHS

Grant: UL1 TR002384

NHLBI NIH HHS

Grant: U24 HL164284

FWCI

152.42

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.nejmgroup.org/legal/terms-of-use.htm

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10564556/pdf/nihms-1927369.pdf

publisherhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2304146

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10564556

journalhttps://doi.org/10.1056/nejmoa2304146

Fields of Study

HIV-related health complications and treatmentsLipoproteins and Cardiovascular HealthHIV/AIDS drug development and treatmentHumansMiddle AgedCardiovascular DiseasesDouble-Blind MethodHIV InfectionsMyocardial InfarctionQuinolinesHydroxymethylglutaryl-CoA Reductase Inhibitors

MeSH Terms

Cardiovascular DiseasesDouble-Blind MethodHumansMiddle AgedMyocardial InfarctionQuinolinesHIV InfectionsHydroxymethylglutaryl-CoA Reductase Inhibitors

Keywords

Human immunodeficiency virus (HIV)MedicinePitavastatinDiseasePopulationVirologyAtherosclerotic cardiovascular diseaseImmunologyIntensive care medicineInternal medicineStatinEnvironmental health

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants

10.6084/m9.figshare.24953157.v1figshare

Additional file 1 of Dyslipidemia among adult people living with HIV on dolutegravir – based antiretroviral therapy at a private tertiary hospital in Kampala, Uganda: burden and determinants

10.6084/m9.figshare.24953157figshare

Additional file 1 of Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana

10.6084/m9.figshare.26353265.v1figshare

Additional file 1 of Quantitative outcomes of a type 2 single arm hybrid effectiveness implementation pilot study for hypertension-HIV integration in Botswana

10.6084/m9.figshare.26353265figshare